Enzzo Barrozo Marrazzo

Enzzo Barrozo Marrazzo

Auto-generated profile, based on publicly available information

Enzzo Barrozo Marrazzo

Rare Diseases Community

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2021 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
PTPaul Truche
Paul Truche
LCLetícia Nunes Campos
Letícia Nunes Campos
EMEnzzo Barrozo Marrazzo
Enzzo Barrozo Marrazzo
ARAyla Gerk Rangel
Ayla Gerk Rangel
RBRamon Bernardino
Ramon Bernardino
NANivaldo Alonso
Nivaldo Alonso
The impact of public health policy to reduce the spread of COVID-19 on access to surgical care is poorly defined. We aim to quantify the surgical backlog during the COVID-19 pandemic in the Brazilian public health system and determine the relationship between state-level policy response and the degree of state-level delays in public surgical care. Monthly estimates of surgical procedures performed per state from January 2016 to December 2020 were obtained from Brazil's Unified Health System Informatics Department. Forecasting models using historical surgical volume data before March 2020 (first reported COVID-19 case) were constructed to predict expected monthly operations from March through December 2020. Total, emergency, and elective surgical monthly backlogs were calculated by comparing reported volume to forecasted volume. Linear mixed effects models were used to model the relationship between public surgical delivery and two measures of health policy response: the COVID-19 Stringency Index (SI) and the Containment & Health Index (CHI) by state. Between March and December 2020, the total surgical backlog included 1,119,433 (95% Confidence Interval 762,663–1,523,995) total operations, 161,321 (95%CI 37,468–395,478) emergent operations, and 928,758 (95%CI 675,202–1,208,769) elective operations. Increased SI and CHI scores were associated with reductions in emergent surgical delays but increases in elective surgical backlogs. The maximum government stringency (score = 100) reduced emergency delays to nearly zero but tripled the elective surgical backlog. Strong health policy efforts to contain COVID-19 ensure minimal reductions in delivery of emergent surgery, but dramatically increase elective backlogs. Additional coordinated government efforts will be necessary to specifically address the increased elective backlogs that accompany stringent responses.

1 January 2025 in Acta Cirurgica Brasileira
Verified
Journal Article
Open access
PDF file
SVSofia Wagemaker Viana
Sofia Wagemaker Viana
AGAyla Ayla Gerk
Ayla Ayla Gerk
SSSofia Schmitt Schlindwein
Sofia Schmitt Schlindwein
EMEnzzo Marrazzo
Enzzo Marrazzo
BFBrenda Feres
Brenda Feres
CCCamargo Pires Camargo
Camargo Pires Camargo
Purpose: To assess the cost of traffic accidents in Brazil and the impact of age/location.

22 October 2024 in World Journal of Surgery
Verified
Journal Article
Closed access
PMPaulo Henrique Moreira Melo
Paulo Henrique Moreira Melo
LTLuiza Telles
Luiza Telles
AGAyla Ayla Gerk
Ayla Ayla Gerk
EMEnzzo Barrozo Marrazzo
Enzzo Barrozo Marrazzo
MCMadeleine Carroll
Madeleine Carroll
GSGabriel Schnitman
Gabriel Schnitman

17 February 2026 in Andes Pediatrica
Verified
Journal Article
Open access
PDF file
SSSofia Schmitt Schlindwein
Sofia Schmitt Schlindwein
EMEnzzo Barrozo Marrazzo
Enzzo Barrozo Marrazzo
LCLetícia Nunes Campos
Letícia Nunes Campos
CACarina Francisca Argüelles
Carina Francisca Argüelles
FZFederico Fernandez Zelcer
Federico Fernandez Zelcer
AGAyla Ayla Gerk
Ayla Ayla Gerk
Mucopolysaccharidosis type II (MPS II), or Hunter syndrome, is a rare lysosomal storage disorder caused by pathogenic variants in the IDS gene. This condition has specific treatment; therefore, timely diagnosis and adequate follow-up are essential for optimizing patient outcomes. Objective: To synthesize the available evidence on diagnostic and follow-up approaches for MPS II. Methods: Scoping review of ten databases for articles published between 2017 and 2022. Studies involving human participants were included if they addressed diagnostic or follow-up methods for MPS II. We followed the PRISMA-ScR guidelines and conducted qualitative analysis and descriptive statistics to identify trends in diagnostic and follow-up practices. Results: 31 articles were selected. Of these, 23 reported clinical findings, with most articles focusing on neurological (n = 17), skeletal and limbs (n = 16), and head and neck (n = 15) manifestations. Enzyme activity testing was the most reported diagnostic method, although the techniques used were frequently unspecified. Follow-up approaches included imaging studies, clinical assessments, and quality-of-life measurement scales. However, the lack of standardization in methodologies limits the generalizability of findings. Conclusion: This review highlights the need for standardized diagnostic and follow-up protocols for MPS II. Greater transparency in reporting diagnostic methods and a consistent follow-up framework are critical to improving patient care and facilitating research comparisons.